You know I have bad timing when it comes to trading but it looks like sooner than later to me. I'm guessing FDA approval is baked in to the current PPS so I wouldn't be shocked to see a little pullback and some more consolidation before the imminent news.
It's always a question mark when they aren't making any money yet.
And there's still a chance that the DEA could try to pull some shit considering the current administration's views on cannabis.
I think the rest of the story hinges on how they market Epidolex, if approved and how much they try to enforce their patents. I've seen the aftermarket CBD oil do wonders for humans and pets alike. In the last 5 years I've personally witnessed two dogs that had cancerous tumors literally disappear from this stuff, let alone all the stories of children who went from up to 100 seizures a day to almost none. These aren't even GW's products so.
Market Data 
Markets 
AI
